Here's Why Nuclear Energy Stocks May Be the Smartest Buys of 2026
A deep dive into the potential of nuclear energy investments for the upcoming year.
Editorial Staff Mar 28
Briefing: The Best 3 Consumer Staples Stocks to Buy and Hold for Decades
Strategic angle: Discover top consumer staples stocks that promise long-term growth and stability.
Editorial Staff Mar 28
Briefing: Berkshire shares suffer longest losing streak in more than 7 years
Strategic angle: Shares of Berkshire Hathaway have lost ground for eight consecutive days, marking their longest losing streak since December 2018.
Editorial Staff Mar 28
NANO Nuclear Energy (NNE) shares significant development on HALEU system
NANO Nuclear Energy announces major advancements in their HALEU technology.
Editorial Staff Mar 28
Briefing: Global markets recoil as Rubio warns war in Iran could stretch for weeks
Strategic angle: Comments from US secretary of state come as oil jumps to $114 and Wall Street stocks slide
Editorial Staff Mar 27
Briefing: Tech stocks suffer worst week in nearly a year, driven down by war worries, Meta legal woes
Strategic angle: Meta's legal challenges and rising oil prices contribute to a significant decline in tech stocks.
Editorial Staff Mar 27
Briefing: Canadian Mining Stocks Report: Weekly Round-Up of 5 Top Performers
Strategic angle: A comprehensive review of the top-performing Canadian mining stocks this week.
Editorial Staff Mar 27
Briefing: The Justice Department plans to share sensitive voter data with Homeland Security
Strategic angle: The Justice Department has sought voter data from states and plans to share it with Homeland Security for a citizenship check.
Editorial Staff Mar 27
Briefing: Wall Street drops again to close its 5th straight losing week and its worst since the Iran war
Strategic angle: Wall Street experiences significant losses, marking its worst performance since the Iran war.
Editorial Staff Mar 27
Briefing: Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug
Strategic angle: Madrigal Pharmaceuticals experiences a significant rise in stock value due to impressive sales figures for its Rezdiffra medication.
Editorial Staff Mar 27
Briefing: This Energy Stock Rallies 25%, Clears Entry As Funds Load Up
Strategic angle: This Energy Stock Rallies 25%, Clears Entry As Funds Load Up
Editorial Staff Mar 27
Briefing: The market is starting to think the Federal Reserve's next move is raising interest rates
Strategic angle: Market speculation indicates a potential increase in interest rates by the Federal Reserve.
Editorial Staff Mar 27
Briefing: Markets now see the Fed's next move as a potential rate hike as inflation fears mount
Strategic angle: Traders in the futures market shifted the probability of a rate increase by the end of 2026 to 52% on Friday morning.
Editorial Staff Mar 27
Briefing: Iran war wipes out $100 billion from luxury stocks
Strategic angle: Middle East tensions impact luxury industry growth, particularly in Dubai.
Editorial Staff Mar 27
Briefing: Here’s What Led to Varonis Systems’ (VRNS) Material Stock Price Overreactions
Strategic angle: An analysis of the factors influencing Varonis Systems' stock price volatility.
Editorial Staff Mar 27
Briefing: Stocks and bonds slump in tandem as Iran shock leaves investors ‘nowhere to hide’
Strategic angle: Traditional 60-40 portfolio of global equities and fixed income on course for worst month since 2022
Editorial Staff Mar 27
Briefing: Donald Trump takes credit for transgender ban at LA's 2028 Olympics
Strategic angle: The former president claims responsibility for the controversial policy affecting transgender athletes.
Editorial Staff Mar 27
Briefing: French prime minister pushes on as 2025 public deficit beats forecasts
Strategic angle: France's public deficit stood at 5.1% of GDP in 2025, exceeding the target of 5.4%, enhancing credibility for future fiscal goals.
Editorial Staff Mar 27
Briefing: Your Insurance Deemed Your Car Totaled: Now What?
Strategic angle: Once your car is totaled, you enter a world where you're not in control of it. And you may find that what the insurance company pays you isn't enough.
Editorial Staff Mar 27
Briefing: Trump administration claims home care fraud is ‘rampant’
Strategic angle: Officials allege widespread fraud in home-based care, but evidence remains unprovided.
Editorial Staff Mar 27